Investors
SEVO Bioscience is building the infrastructure layer for how therapeutics are delivered in aquaculture — scalable, feed-delivered, and powered by our proprietary ANKR™ platform.
Download OverviewAquaculture supplies more than half of the seafood consumed globally. Yet disease outbreaks remain one of the most significant risks in fish production. Current prevention strategies rely heavily on labor-intensive injection protocols — costly, logistically complex, and difficult to scale.
The industry does not lack therapeutic targets. It lacks scalable delivery systems.
Injection-based vaccination requires intensive manual handling at every production stage.
Physical handling during injection causes stress, reducing fish health and yield.
Injection protocols become increasingly strained as aquaculture operations grow.
Current delivery models introduce logistical friction that limits operational flexibility.
Feed-delivered therapeutics represent a structural shift in aquaculture health — no manual injection, lower labor intensity, reduced fish stress, and broader population coverage. The shift is not incremental. It is architectural.
Aquaculture supplies 50%+ of global seafood consumption and is growing.
Rising demand, regulatory pressure, and advances in synthetic biology create a timing window.
A proprietary biological protein stacking system enabling scalable therapeutic delivery through feed.
One platform. Multiple disease targets. Expanding across species and geographies.
SEVO is structured to focus on high-value infrastructure, not downstream commoditized production. We design the biological engine that partners deploy.
Core innovation stays proprietary. We own the platform and license the application.
Strategic licensing model enables global scale without manufacturing complexity.
We partner with feed manufacturers and aquaculture operators for deployment at scale.
One platform enables multiple therapeutic programs across species and diseases.
Download our overview or reach out directly to learn more about SEVO Bioscience's vision and opportunity.